
ABOUT EXCELLOS
As a strategically focused CDMO, Excellos combines the best of both worlds: the tailored, consultative support of a boutique firm with the scientific and operational strength needed to support complex, high-stakes programs. We offer bespoke solutions across the full development lifecycle, from donor-sourced starting material to final product characterization. Our model is intentionally focused: we’re structured to move quickly, collaborate deeply, and adapt to your unique needs without compromising quality or scalability. With a foundation rooted in clinical experience, a close partnership with the San Diego Blood Bank, and a culture of scientific rigor, Excellos brings both precision and flexibility to every engagement — helping our partners accelerate progress with confidence.
INDUSTRY INSIGHTS
-
With hundreds of members spanning over 25 countries, ARM serves as a hub for innovation, policy development, and cross-sector collaboration in regenerative medicine.
-
Leverage our proven cGMP expertise in cell therapy manufacturing, from primary tissue processing to large-scale production for clinical trials.
-
To ensure the safety of tumor-infiltrating leukocytes (TIL) therapies, it's important to use cGMP-compliant feeder cells confirmed to be non-proliferative through competency testing.
-
A QA team at a cell therapy CDMO ensures all aspects of development and manufacturing meet the highest standards of quality, safety, and regulatory compliance.
CONTACT INFORMATION
Excellos
1155 Island Ave, Suite 400
San Diego, CA 92101
UNITED STATES
Phone: (619) 496-7001
Contact: Jessica Wanamaker, VP of Business Development
SOLUTIONS
-
Ready to go deeper on cell characterization? Advance past typical cell and donor screening to create a comprehensive immune cell profile for each donor as well as an assessment of the metabolic and effector potential of their cells. See beyond surface markers too.
-
Now that you have the best donated cellular material, it is time to optimize your cell therapy process for cGMP manufacturing. We offer R&D services including process development and cGMP production for Phase I through Commercial manufacturing.